InsiderTrades

Form 4 for LLY Lilly (Eli)

Accepted 2026-02-18 00:00:00 ET · period of report 2026-02-16 · accession 0001561539-26-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-02-18 2026-02-16 LLY Zakrowski Donald A SVP, CAO, Fin M - OptEx $0.00 +184 3,607 +5% $0
D 2026-02-18 2026-02-16 LLY Zakrowski Donald A SVP, CAO, Fin F - Tax $1,040.00 -81.55 3,526 -2% -$84.8K
D 2026-02-18 2026-02-16 LLY Zakrowski Donald A SVP, CAO, Fin M - OptEx $0.00 -184 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-16 M A 184 $0.00 3,607.44 D — —
2 Common Common Stock 2026-02-16 F D 81.55 $1,040.00 3,525.89 D — — (F1) The reported amount includes 7.458 shares previously withheld to satisfy tax withholding obligations arising prior to the vesting date of this award.
3 Derivative Restricted Stock Unit 2026-02-16 M D 184 $0.00 0 D — · 2026-02-16 to 2026-02-16 184 Common Stock (F2) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.